Public-registry site landscape for NCT07740733, a Tetanus study sponsored by Beijing Minhai Biotechnology Co., Ltd. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07740733 (registry record) |
| Sponsor | Beijing Minhai Biotechnology Co., Ltd |
| Condition(s) | Tetanus; Tetanus Vaccine |
| Phase | PHASE3 |
| Listed sites | 1 |
| Site countries | China |
Eichor generates a preliminary site-risk snapshot for NCT07740733 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →